Constitutively phosphorylated Smad3 interacts with Sp1 and p300 in scleroderma fibroblasts

Rheumatology

Volumn 45, Issue 2, 2006, Pages 157-165

  Ihn, H ^a   Yamane, K ^a   Asano, Y ^a   Jinnin, M ^a   Tamaki, K ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Collagen diseases; Connective tissue; Cytokines

Indexed keywords

CHLORAMPHENICOL ACETYLTRANSFERASE; COLLAGEN; PROTEIN P300; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD4 PROTEIN; TRANSCRIPTION FACTOR SP1; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FIBROBLAST; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOPRECIPITATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; SCLERODERMA; SIGNAL TRANSDUCTION;

CELLS, CULTURED; COLLAGEN; E1A-ASSOCIATED P300 PROTEIN; FIBROBLASTS; GENE EXPRESSION REGULATION; HUMANS; PHOSPHORYLATION; RECOMBINANT PROTEINS; SCLERODERMA, SYSTEMIC; SKIN; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD4 PROTEIN; SP1 TRANSCRIPTION FACTOR; TRANS-ACTIVATION (GENETICS); TRANSFORMING GROWTH FACTOR BETA;

EID: 31544442502     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kei124     Document Type: Article

References (61)

1. LeRoy EC. Systemic sclerosis (scleroderma). In: Wyngaarden JB, Smith LH, Bennett JC, eds. Cecil text book of medicines, 19th edn. Philadelphia, PA: WB Saunders, 1992:1530-5.
2. Medsger TA Jr. Systemic sclerosis (scleroderma): Clinical aspects. In: McCarty DJ, Koopman WJ, eds. Arthritis and allied conditions. Baltimore, MD: Williams and Wilkins, 1997: 1433-63.
3. LeRoy EC. A brief overview of the pathogenesis of scleroderma. Ann Rheum Dis 1992;51:286-8.
4. Jimenez SA, Hitraya E, Varga J. Pathogenesis of scleroderma. Collagen. Rheum Dis Clin North Am 1996;22:647-74.
5. Kulozik K, Hogg A, Lankat-Buttgereit B, Kreig T. Co-localization of transforming growth factor β2 with α1(I) collagen mRNA in tissue sections of patients with systemic sclerosis. J Clin Invest 1990;86:917-22.
6. Jelaska A, Arakawa M, Broketa G, Korn JH. Heterogeneity of collagen synthesis in normal and systemic sclerosis skin fibroblasts: Increased proportion of high collagen-producing cells in systemic sclerosis fibroblasts. Arthritis Rheum 1996;39: 1338-46.
7. LeRoy EC. Increased collagen synthesis by scleroderma skin fibroblasts in vivo. J Clin Invest 1974;54:880-9.
8. Peltonen J, Kahari L, Uitto J, Jimenez SA. Increased expression of type VI collagen genes in systemic sclerosis. Arthritis Rheum 1990; 33:1829-35.
9. Xu W, LeRoy EC, Smith EA. Fibronectin release by systemic sclerosis and normal dermal fibroblasts in response to TGF-β. J Rheumatol 1991;18:241-6.
10. Ludnicka L, Varga J, Christiano AM, Iozzo RV, Jimenez SA, Uitto J. Elevated expression of type VII collagen in the skin of patients with systemic sclerosis: Regulation by transforming growth factor-β. J Clin Invest 1994;93:1709-15.
11. Falanga V, Tiegs SL, Alstadt SP, Roberts AB, Sporn MB. Transforming growth factor β: Selective increase in glycosaminoglycan synthesis by cultures of fibroblasts from patients with progressive systemic sclerosis. J Invest Dermatol 1987;89:100-4.
12. Kirk TZ, Mark ME, Chua CC, Chua BH, Mayes MD. Myofibroblasts from scleroderma skin synthesize elevated levels of collagen and tissue inhibitor of metalloproteinase (TIMP)-1 with two forms of TIMP-1. J Biol Chem 1995;270:3423-8.
13. Ihn H, Sato S, Fujimoto M et al. Circulating intercellular adhesion molecule-1 in the sera of patients with systemic sclerosis: Enhancement by inflammatory cytokines. Br J Rheumatol 1997;36:1270-5.
14. Abraham D, Lupoli S, McWhirter A et al. Expression and function of surface antigens on scleroderma fibroblasts. Arthritis Rheum 1991;34:1164-72.
15. Ihn H, Tamaki K. Increased phosphorylation of transcription factor Sp1 in scleroderma fibroblasts: Association with increased expression of the type I collagen gene. Arthritis Rheum 2000;43:2240-7.
16. Hitraya EG, Jimenez SA. Transcriptional activation of the α1(I) collagen gene in systemic sclerosis dermal fibroblasts: Role of intronic sequences. Arthritis Rheum 1996;39:1347-54.
17. Massagué J. The transforming growth factor-β family. Annu Rev Cell Biol 1990;6:597-641.
18. LeRoy EC, Smith EA, Kahaleh MB, Trojanowska M, Silver RM. Strategy for determining the pathogenesis of systemic sclerosis: Is transforming growth factor β the answer? Arthritis Rheum 1989; 32:817-25.
19. Kawakami T, Ihn H, Xu W, Smith E, LeRoy EC, Trojanowska M. Increased expression of TGF-β receptors by scleroderma fibroblasts: Evidence for contribution of autocrine TGF-β signaling to scleroderma phenotype. J Invest Dermatol 1998;110:47-51.
20. Ihn H, Tamaki K. Blockade of endogenous transforming growth factor β signaling prevents up-regulated collagen synthesis in scleroderma fibroblasts: Association with increased expression of transforming growth factor β receptors. Arthritis Rheum 2001;44: 474-80.
21. Vuorio E, de Crombrugghe B. The family of collagen genes. Annu Rev Biochem 1990;59:837-72.
22. Boast S, Su MW, Ramirez F, Sanchez M, Avvedimento EV. Functional analysis of cis-acting DNA sequences controlling transcription of the human type I collagen gene. J Biol Chem 1990;265:13351-6.
23. Inagaki Y, Truter S, Ramirez F. Transforming growth factor-β stimulates α2(I) collagen gene expression through a cis-acting element that contains an Sp1-binding site. J Biol Chem 1994;269:14828-34.
24. Ihn H, Ohnishi K, Tamaki T, LeRoy EC, Trojanowska M. Transcriptional regulation of the human α2(I) collagen gene: Combined action of upstream stimulatory and inhibitory cis-acting elements. J Biol Chem 1996;271:26717-23.
25. Ihn H, LeRoy EC, Trojanowska M. Oncostatin M stimulates transcription of the human α2(I) collagen gene via the Sp1/Sp3-binding site. J Biol Chem 1997;272:24666-72.
26. Ihn H, Trojanowska M. Sp3 is a transcriptional activator of the human α2(I) collagen gene. Nucleic Acids Res 1997;25:3712-17.
27. Greenwel P, Inagaki Y, Hu W, Walsh M, Ramirez F. Sp1 is required for the early response of α2(I) collagen to transforming growth factor-β1. J Biol Chem 1997;272:19738-45.
28. Chen SJ, Yuan W, Mori Y, Levenson A, Trojanowska M, Varga J. Stimulation of type I collagen transcription in human skin fibroblasts by TGF-β: involvement of Smad3. J Invest Dermatol 1999;112:49-57.
29. Chen SJ, Yuan W, Lo S, Trojanowska M, Varga J. Interaction of Smad3 with a proximal Smad-binding element of the human α2(I) collagen gene promoter required for transcriptional activation by TGF-β. J Cell Physiol 2000;183:381-92.
30. Zhang W, Ou J, Inagaki Y, Greenwel P, Ramirez F. Synergistic cooperation between Sp1 and Smad3/Smad4 modulates transforming growth factor-β1 stimulation of α2(I) collagen (COL1A2) transcription. J Biol Chem 2000;275:39237-45.
31. Poncelet AC, Schnaper HW. Sp1 and Smad proteins cooperate to mediate transforming growth factor-β1-induced α2(I) collagen expression in human glomerular mesangial cells. J Biol Chem 2001; 276:6983-92.
32. Ghosh AK, Yuan W, Mori Y, Varga J. Smad-dependent stimulation of type I collagen gene expression in human skin fibroblasts by TGF-β involves functional cooperation with p300/CBP transcriptional coactivators. Oncogene 2000;19:3546-55.
33. Ghosh AK, Yuan W, Mori Y, Chen SJ, Varga J. Antagonistic regulation of type I collagen gene expression by interferon-γ and transforming growth factor-β. Integration at the level of p300/CBP transcriptional coactivators. J Biol Chem 2001;276: 11041-8.
34. Ihn H, Tamaki K. Oncostatin M stimulates the growth of dermal fibroblasts via a mitogen-activated protein kinase-dependent pathway. J Immunol 2000;165:2149-55.
35. Ihn H, Tamaki K. Competition analysis of the human α2(I) collagen promoter using synthetic oligonucleotides. J Invest Dermatol 2000; 114:1011-16.
36. Ihn H, Ihn Y, Trojanowska M. Sp1 phosphorylation induced by serum stimulates the human α2(I) collagen gene expression. J Invest Dermatol 2001;117:301-8.
37. Ihn H, Yamane K, Asano Y, Kubo M, Tamaki K. Interleukin-4 up-regulates the expression of tissue inhibitor of metalloproteinase-2 in dermal fibroblasts via the p38 mitogen-activated protein kinase-dependent pathway. J Immunol 2002;168:1895-902.
38. Hoodless PA, Haerry T, Abdollah S et al. MADR1, a MAD-related protein that functions in BMP2 signaling pathways. Cell 1996; 85:489-500.
39. Liu X, Sun Y, Constantinescu SN, Karam E, Weinberg RA, Lodish HF. Transforming growth factor β-induced phosphorylation of Smad3 is required for growth inhibition and transcriptional induction in epithelial cells. Proc Natl Acad Sci USA 1997;94: 10669-74.
40. Zhang Y, Feng X, Wu R, Derynck R. Receptor-associated Mad homologues synergize as effectors of the TGF-β response. Nature 1996;383:168-71.
41. Massagué J, Chen YG. Controlling TGF-β signaling. Genes Dev 2000;14:627-44.
42. Ihn H. Pathogenesis of fibrosis: Role of TGF-β and CTGF. Curr Opin Rheumatol 2002;14:681-5.
43. Ihn H. The role of TGF-β signaling in the pathogenesis of fibrosis in scleroderma. Arch Immunol Ther Exp 2002;50:325-31.
44. Needleman BW, Choi J, Burrows-Mezu A, Fontana JA. Secretion and binding of transforming growth factor β by scleroderma and normal dermal fibroblasts. Arthritis Rheum 1990;33:650-6.
45. Yamane K, Ihn H, Kubo M, Tamaki K. Increased transcriptional activities of transforming growth factor-β receptors in scleroderma fibroblasts. Arthritis Rheum 2002;46:2421-8.
46. Kubo M, Ihn H, Yamane K, Tamaki K. Up-regulated expression of transforming growth factor β receptors in dermal fibroblasts of the skin sections from patients with systemic sclerosis. J Rheumatol 2002;29:2558-64.
47. Asano Y, Ihn H, Yamane K, Kubo M, Tamaki K. Impaired Smad7-Smurf-mediated negative regulation of TGF-β signaling in scleroderma fibroblasts. J Clin Invest 2004;113:253-64.
48. Kretzschmar M, Massaguë J. SMADs: Mediators and regulators of TGF-β signaling. Curr Opin Genet Dev 1998;8:103-11.
49. Kawabata M, Inoue H, Hanyu A, Imamura T, Miyazono K. Smads proteins exist as monomers in vivo and undergo homo- and hetero-oligomerization upon activation by serine/threonine kinase receptor. EMBO J 1998;17:4056-65.
50. Asano Y, Ihn H, Yamane K, Kubo M, Tamaki K. Impaired Smad7-Smurf-mediated negative regulation of TGF-β signaling in scleroderma fibroblasts. J Clin Invest 2004;113:253-64.
51. Mimura Y, Ihn H, Jinnin M, Asano Y, Yamane K, Tamaki K. Constitutive thrombospondin-1 overexpression contributes to autocrine transforming growth factor-β signaling in cultured scleroderma fibroblasts. Am J Pathol 2005;166:1451-63.
52. Verrecchia F, Rossert J, Mauviel A. Blocking Sp1 transcription factor broadly inhibits extracellular matrix gene expression in vitro and in vivo: Implications for the treatment of tissue fibrosis. J Invest Dermatol 2001;116:755-63.
53. Inagaki Y, Nemoto T, Nakao A et al. Interaction between GC box binding factors and Smad proteins modulates cell lineage-specific α2(I) collagen gene transcription. J Biol Chem 2001;276:16573-9.
54. Flanders KC, Sullivan CD, Fujii M et al. Mice lacking Smad3 are protected against cutaneous injury induced by ionizing radiation. Am J Pathol 2002;160:1057-68.
55. Zhao J, Shi W, Wang YL et al. Smad3 deficiency attenuates bleomycin-induced pulmonary fibrosis in mice. Am J Physiol Lung Cell Mol Physiol 2002;282:585-93.
56. Lee DK, Park SH, Yi Y et al. The hepatitis B virus encoded oncoprotein pX amplifies TGF-β family signaling through direct interaction with Smad4: Potential mechanism of hepatitis B virus-induced liver fibrosis. Genes Dev 2001;15:455-66.
57. Schnabl B, Kweon YO, Frederick JP, Wang XF, Rippe RA, Brenner DA. The role of Smad3 in mediating mouse hepatic stellate cell activation. Hepatology 2001;34:89-100.
58. Inagaki Y, Mamura M, Kanamaru Y et al. Constitutive phosphorylation and nuclear localization of Smad3 are correlated with increased collagen gene transcription in activated hepatic satellate cells. J Cell Physiol 2001;187:117-23.
59. Holmes A, Abraham DJ, Sa S, Shiwen X, Black CM, Leask A. CTGF and SMADs, maintenance of scleroderma phenotype is independent of SMAD signaling. J Biol Chem 2001;276:10594-601.
60. Dong C, Zhu S, Wang T et al. Deficient Smad7 expression: A putative molecular defect in scleroderma. Proc Natl Acad Sci USA 2002; 99:3908-13.
61. Mori Y, Chen SJ, Varga J. Expression and regulation of intracellular SMAD signaling in scleroderma skin fibroblasts. Arthritis Rheum 2003;48:1964-78.